dolutegravir

Zimbabweans living with HIV and on the Second regimen of the antiretroviral may be forced to default or change one of their drugs following an announcement that there is a nationwide shortage of second line medication.
Read More...

The United States (US) has supplied Zimbabwe with 2,1 million bottles of Dolutegravir (DTG), a new antiretroviral drug which is more effective in viral suppression and has fewer side effects than Efavirenz.
Read More...

Newly diagnosed HIV patients are now being initiated onto a new regimen of antiretroviral medication containing Dolutegravir (DTG), a drug which has significantly less side effects and is more affordable compared to the current line.
Read More...

Government has deferred the national rollout of dolutegravir, an anti-retroviral drug, to adolescent girls and women of child-bearing age, following reports from Botswana that the drug was associated with birth deformities in infants born…
Read More...